Riso Kagaku Corporation TSE:6413

Riso Kagaku : Consolidated Financial Results for the Fiscal Year Ended March 31, 2026(under Japanese GAAP)【PDF:355KB】

Published

Source: MarketScreener

Note: This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.



May 8, 2026

Consolidated Financial Results for the Fiscal Year Ended March 31, 2026 (under Japanese GAAP)

Company name: RISO KAGAKU CORPORATION Listing: Tokyo Stock Exchange Prime Market Securities code: 6413

URL: https://www.riso.co.jp/english/ Representative: Akira Hayama, President & CEO

Inquiries: Yoshiomi Narumiya, Director and General Manager of Corporate Headquarters Telephone: +81-3-5441-6611 (from overseas)

Scheduled date of annual general meeting of shareholders: June 24, 2026 Scheduled date to commence dividend payments: June 25, 2026 Scheduled date to file annual securities report: June 18, 2026 Preparation of supplementary material on financial results: Yes

Holding of financial results briefing: Yes (Recorded video of briefing on business results

scheduled for distribution)

(Yen amounts are rounded down to millions, unless otherwise noted.)

  1. Consolidated financial results for the fiscal year ended March 31, 2026 (from April 1, 2025 to March 31, 2026)
    1. Consolidated operating results (Percentages indicate year-on-year changes.)

      Net sales

      Operating profit

      Ordinary profit

      Profit attributable to owners of parent

      Fiscal year ended

      Millions of yen

      %

      Millions of yen

      %

      Millions of yen

      %

      Millions of yen

      %

      March 31, 2026

      78,990

      0.3

      5,111

      (17.3)

      5,872

      (7.7)

      4,378

      7.1

      March 31, 2025

      78,723

      5.5

      6,183

      17.6

      6,364

      2.6

      4,088

      (15.4)

      Note: Comprehensive income

      For the fiscal year ended March 31, 2026:

      ¥6,992 million

      [29.5%]

      For the fiscal year ended March 31, 2025:

      ¥5,398 million

      [(33.4)%]

      Basic earnings per share

      Diluted earnings per share

      Return on equity

      Ratio of ordinary profit to total assets

      Ratio of operating profit to net sales

      Fiscal year ended

      Yen

      Yen

      %

      %

      %

      March 31, 2026

      68.71

      -

      6.5

      6.4

      6.5

      March 31, 2025

      62.80

      -

      6.1

      7.2

      7.9

      Reference: Share of profit (loss) of entities accounted for using equity method For the fiscal year ended March 31, 2026: ¥-million

      For the fiscal year ended March 31, 2025: ¥-million

      A two-for-one split of its common shares was conducted on January 1, 2025. As a result, net income per share stated above was calculated based on the assumption that the two-for-one stock split took place at the beginning of the fiscal year ended March 31, 2025.

    2. Consolidated financial position

      Total assets

      Net assets

      Equity-to-asset ratio

      Net assets per share

      As of

      Millions of yen

      Millions of yen

      %

      Yen

      March 31, 2026

      95,201

      68,792

      72.3

      1,093.58

      March 31, 2025

      88,911

      66,505

      74.8

      1,037.20

      Reference: Equity

      As of March 31, 2026: ¥68,792 million

      As of March 31, 2025: ¥66,505 million

    3. Consolidated cash flows

    Cash flows from operating activities

    Cash flows from investing activities

    Cash flows from financing activities

    Cash and cash equivalents at end of period

    Fiscal year ended

    Millions of yen

    Millions of yen

    Millions of yen

    Millions of yen

    March 31, 2026

    7,513

    (3,247)

    (3,200)

    15,533

    March 31, 2025

    3,347

    (8,303)

    (1,465)

    13,706

  2. Cash dividends

    Annual dividends per share

    Total cash dividends (Total)

    Payout ratio (Consolidated)

    Ratio of dividends to net assets (Consolidated)

    First quarter-end

    Second quarter-end

    Third quarter-end

    Fiscal year-end

    Total

    Yen

    Yen

    Yen

    Yen

    Yen

    Millions of yen

    %

    %

    Fiscal year ended March 31, 2025

    -

    0.00

    -

    50.00

    50.00

    3,206

    79.6

    4.9

    Fiscal year ended March 31, 2026

    -

    0.00

    -

    50.00

    50.00

    3,145

    72.8

    4.7

    Fiscal year ending March 31, 2027 (Forecast)

    -

    0.00

    -

    50.00

    50.00



    76.7



  3. Forecasts for the fiscal year ending March 31, 2027 (from April 1, 2026 to March 31, 2027)

(Percentages indicate year-on-year changes.)

Net sales

Operating

profit

Ordinary profit

Profit attributable to owners of parent

Net income per share

Millions of

yen

%

Millions of

yen

%

Millions of

yen

%

Millions of

yen

%

Yen

Six months ending September 30, 2026

39,000

3.7

2,300

(9.5)

2,400

(14.6)

2,200

22.8

34.97

Fiscal year ending March 31, 2027

80,900

2.4

4,900

(4.1)

5,100

(13.1)

4,100

(6.4)

65.18

* Notes
  1. Significant changes in the scope of consolidation during the period: None

  2. Changes in accounting policies, changes in accounting estimates, and restatement

    1. Changes in accounting policies due to revisions to accounting standards and other regulations: None

    2. Changes in accounting policies due to other reasons: None

    3. Changes in accounting estimates: None

    4. Restatement: None

  3. Number of issued shares (common shares)

    1. Total number of issued shares at the end of the period (including treasury shares)

      As of March 31, 2026

      72,000,000 shares

      As of March 31, 2025

      72,000,000 shares

    2. Number of treasury shares at the end of the period

      As of March 31, 2026

      9,094,616 shares

      As of March 31, 2025

      7,879,016 shares

    3. Average number of shares outstanding during the period

Fiscal year ended March 31, 2026

63,722,575 shares

Fiscal year ended March 31, 2025

65,095,968 shares

A two-for-one split of its common shares was conducted on January 1, 2025. As a result, average number of shares outstanding during the period above was calculated based on the assumption that the two-for-one stock split took place at the beginning of the fiscal year ended March 31, 2025.

(Reference) Overview of non-consolidated financial results 1. Non-consolidated financial results for the fiscal year ended March 31, 2026 (from April 1, 2025 to March 31, 2026)
  1. Non-consolidated operating results (Percentages indicate year-on-year changes.)

    Net sales

    Operating profit

    Ordinary profit

    Profit

    Fiscal year ended

    Millions of yen

    %

    Millions of yen

    %

    Millions of yen

    %

    Millions of yen

    %

    March 31, 2026

    57,187

    (3.1)

    2,580

    (41.7)

    4,873

    (22.1)

    4,391

    (12.4)

    March 31, 2025

    58,989

    3.6

    4,427

    18.9

    6,256

    2.6

    5,014

    (1.9)

    Basic earnings per share

    Diluted earnings per share

    Fiscal year ended

    Yen

    Yen

    March 31, 2026

    68.91

    -

    March 31, 2025

    77.04

    -

    A two-for-one split of its common shares was conducted on January 1, 2025. As a result, number of net income per share stated above was calculated based on the assumption that the two-for-one stock split took place at the beginning of the fiscal year ended March 31, 2025.

  2. Non-consolidated financial position

Total assets

Net assets

Equity-to-asset ratio

Net assets per share

As of

Millions of yen

Millions of yen

%

Yen

March 31, 2026

78,320

58,308

74.4

926.92

March 31, 2025

74,974

57,899

77.2

902.98

Reference: Equity

As of March 31, 2026: ¥58,308 million

As of March 31, 2025: ¥57,899 million

  • Review of the attached financial statements by a certified public accountant or audit firm: None

  • Proper use of the forecasts, and other special matters

The forward-looking statements, including forecasts, contained in these materials are based on information currently available to the Company. These statements do not purport that the Company pledges to achieve such performance. Actual business may differ substantially from the forecasts due to various factors in the future.

Consolidated Financial Statements Consolidated balance sheets

(Millions of yen)



As of March 31, 2025 As of March 31, 2026

Assets

Current assets

Cash and deposits

13,610

15,499

Notes receivable - trade

831

880

Accounts receivable - trade

12,773

13,524

Securities

218

110

Merchandise and finished goods

7,651

7,397

Work in process

789

787

Raw materials and supplies

2,542

2,744

Other

2,989

3,203

Allowance for doubtful accounts

(174)

(162)

Total current assets

41,232

43,983

Non-current assets

Property, plant and equipment

Buildings and structures

23,982

24,381

Accumulated depreciation

(16,895)

(17,585)

Buildings and structures, net

7,087

6,796

Machinery, equipment and vehicles

7,450

8,224

Accumulated depreciation

(6,485)

(6,869)

Machinery, equipment and vehicles, net

965

1,355

Tools, furniture and fixtures

12,897

13,767

Accumulated depreciation

(12,093)

(12,572)

Tools, furniture and fixtures, net

803

1,194

Land

17,755

17,786

Leased assets

310

280

Accumulated depreciation

(126)

(146)

Leased assets, net

183

133

Construction in progress

582

738

Other

9,304

9,524

Accumulated depreciation

(7,510)

(7,692)

Other, net

1,794

1,831

Total property, plant and equipment

29,172

29,836

Intangible assets

Goodwill

2,308

1,764

Software

1,104

1,377

Other

2,027

1,788

Total intangible assets

5,440

4,931

Investments and other assets

Investment securities

4,288

6,911

Long-term loans receivable

10

9

Deferred tax assets

1,631

1,444

Retirement benefit asset

3,574

4,670

Other

3,574

3,424

Allowance for doubtful accounts

(12)

(9)

Total investments and other assets

13,066

16,449

Total non-current assets

47,678

51,218

Total assets

88,911

95,201



Liabilities

(Millions of yen) As of March 31, 2025 As of March 31, 2026

Current liabilities

Notes and accounts payable - trade

5,556

5,406

Short-term borrowings

1,404

3,530

Current portion of long-term borrowings

563

751

Income taxes payable

788

800

Provision for bonuses

1,992

2,167

Provision for bonuses for directors (and other officers)

52

43

Provision for product warranties

27

305

Other

7,607

8,710

Total current liabilities

17,990

21,716

Non-current liabilities

Long-term borrowings

2,445

1,693

Deferred tax liabilities

31

592

Retirement benefit liability

718

1,504

Other

1,220

902

Total non-current liabilities

4,414

4,693

Total liabilities

22,405

26,409

Net assets

Shareholders' equity

Share capital

14,114

14,114

Capital surplus

14,779

14,779

Retained earnings

38,213

39,386

Treasury shares

(8,315)

(9,815)

Total shareholders' equity

58,792

58,465

Accumulated other comprehensive income

Valuation difference on available-for-sale securities

2,212

2,936

Foreign currency translation adjustment

3,138

4,844

Remeasurements of defined benefit plans

2,362

2,546

Total accumulated other comprehensive income

7,713

10,327

Total net assets

66,505

68,792

Total liabilities and net assets

88,911

95,201

Consolidated statements of income and comprehensive income

(Consolidated statements of income)

(Millions of yen)

Fiscal year ended March 31, 2025

Fiscal year ended March 31, 2026

Net sales

78,723

78,990

Cost of sales

31,693

31,765

Gross profit

47,029

47,225

Selling, general and administrative expenses

40,846

42,113

Operating profit

6,183

5,111

Non-operating income

Interest income

283

251

Dividend income

119

155

Foreign exchange gains

-

303

Other

219

216

Total non-operating income

622

927

Non-operating expenses

Interest expenses

50

92

Foreign exchange losses

319

-

Loss on retirement of non-current assets

22

20

Other

49

54

Total non-operating expenses

442

167

Ordinary profit

6,364

5,872

Extraordinary income

Gain on sale of investment securities

-

677

Insurance return

68

73

Total extraordinary income

68

751

Extraordinary losses

Loss on liquidation of subsidiaries

-

101

Loss on valuation of investment securities

-

87

Impairment losses

219

75

Business restructuring expenses

490

-

Total extraordinary losses

709

264

Profit before income taxes

5,723

6,359

Income taxes - current

1,682

1,671

Income taxes - deferred

(47)

309

Total income taxes

1,634

1,980

Profit

4,088

4,378

Profit attributable to owners of parent

4,088

4,378

(Consolidated statements of comprehensive income)

(Millions of yen)

Fiscal year ended March 31, 2025

Fiscal year ended March 31, 2026

Profit

4,088

4,378

Other comprehensive income

Valuation difference on available-for-sale securities

503

723

Foreign currency translation adjustment

30

1,705

Remeasurements of defined benefit plans, net of tax

776

184

Total other comprehensive income

1,309

2,613

Comprehensive income

5,398

6,992

Comprehensive income attributable to

Comprehensive income attributable to owners of parent

5,398

6,992

Comprehensive income attributable to non-controlling - -

interests

Consolidated statements of changes in net assets Fiscal year ended March 31, 2025

(Millions of yen)

Shareholders' equity

Share capital

Capital surplus

Retained earnings

Treasury shares

Total shareholders' equity

Balance at beginning of period

14,114

14,779

37,410

(5,815)

60,489

Changes during period

Dividends of surplus

(3,284)

(3,284)

Profit attributable to owners of parent

4,088

4,088

Purchase of treasury shares

(2,500)

(2,500)

Net changes in items other than shareholders' equity

Total changes during period

-

-

803

(2,500)

(1,696)

Balance at end of period

14,114

14,779

38,213

(8,315)

58,792

Accumulated other comprehensive income

Total net assets

Valuation difference

on available-for-sale securities

Foreign currency translation adjustment

Remeasurements of defined benefit plans

Total accumulated

other comprehensive income

Balance at beginning of period

1,709

3,108

1,585

6,403

66,893

Changes during period

Dividends of surplus

(3,284)

Profit attributable to owners of parent

4,088

Purchase of treasury shares

(2,500)

Net changes in items other than shareholders' equity

503

30

776

1,309

1,309

Total changes during period

503

30

776

1,309

(387)

Balance at end of period

2,212

3,138

2,362

7,713

66,505

Fiscal year ended March 31, 2026

(Millions of yen)

Shareholders' equity

Share capital

Capital surplus

Retained earnings

Treasury shares

Total shareholders' equity

Balance at beginning of period

14,114

14,779

38,213

(8,315)

58,792

Changes during period

Dividends of surplus

(3,206)

(3,206)

Profit attributable to owners of parent

4,378

4,378

Purchase of treasury shares

(1,499)

(1,499)

Net changes in items other than shareholders' equity

Total changes during period

-

-

1,172

(1,499)

(327)

Balance at end of period

14,114

14,779

39,386

(9,815)

58,465

Accumulated other comprehensive income

Total net assets

Valuation difference

on available-for-sale securities

Foreign currency translation adjustment

Remeasurements of defined benefit plans

Total accumulated

other comprehensive income

Balance at beginning of period

2,212

3,138

2,362

7,713

66,505

Changes during period

Dividends of surplus

(3,206)

Profit attributable to owners of parent

4,378

Purchase of treasury shares

(1,499)

Net changes in items other than shareholders' equity

723

1,705

184

2,613

2,613

Total changes during period

723

1,705

184

2,613

2,286

Balance at end of period

2,936

4,844

2,546

10,327

68,792

Consolidated statements of cash flows

(Millions of yen)

Fiscal year ended

Fiscal year ended

March 31, 2025

March 31, 2026

Cash flows from operating activities

Profit before income taxes

5,723

6,359

Depreciation

3,096

3,223

Impairment losses

219

75

Amortization of goodwill

407

543

Decrease (increase) in retirement benefit asset

(361)

(812)

Increase (decrease) in retirement benefit liability

(32)

712

Increase (decrease) in provision for bonuses for directors

3

(8)

(and other officers)

Increase (decrease) in allowance for doubtful accounts

(33)

(31)

Interest and dividend income

(403)

(407)

Interest expenses

50

92

Foreign exchange losses (gains)

28

(294)

Loss (gain) on sale of investment securities

-

(677)

Loss (gain) on valuation of investment securities

-

87

Gain on maturity of insurance contract

(68)

(73)

Restructuring expenses - OpeCF

490

-

Decrease (increase) in trade receivables

362

149

Decrease (increase) in inventories

522

906

Increase (decrease) in trade payables

(3,660)

(974)

Increase (decrease) in accounts payable - other

(188)

10

Increase (decrease) in accrued consumption taxes

66

8

Other, net

(1,015)

(21)

Subtotal

5,207

8,866

Interest and dividends received

408

416

Interest paid

(51)

(92)

Payments for restructuring -OpeCF

(490)

-

Income taxes paid

(1,726)

(1,677)

Income taxes refund

0

-

Net cash provided by (used in) operating activities

3,347

7,513

Cash flows from investing activities

Payments into time deposits

(406)

(54)

Proceeds from withdrawal of time deposits

1,769

181

Purchase of property, plant and equipment

(1,753)

(1,513)

Proceeds from sale of property, plant and equipment

17

30

Purchase of intangible assets

(991)

(944)

Purchase of investment securities

-

(1,891)

Proceeds from sale of investment securities

-

920

Payments for absorption-type split

(6,750)

-

Proceeds from maturity of insurance funds

138

147

Other, net

(326)

(123)

Net cash provided by (used in) investing activities

(8,303)

(3,247)

Cash flows from financing activities

Net increase (decrease) in short-term borrowings

1,388

2,124

Proceeds from long-term borrowings

3,000

-

Repayments of long-term borrowings

(1)

(563)

Purchase of treasury shares

(2,499)

(1,499)

Repayments of lease liabilities

(68)

(56)

Dividends paid

(3,284)

(3,205)

Other, net

(0)

-

Net cash provided by (used in) financing activities

(1,465)

(3,200)

Effect of exchange rate change on cash and cash equivalents

39

760

Net increase (decrease) in cash and cash equivalents

(6,381)

1,826

Cash and cash equivalents at beginning of period

20,088

13,706

Cash and cash equivalents at end of period

13,706

15,533